172 related articles for article (PubMed ID: 28472639)
1. Post-injury administration of a combination of memantine and 17β-estradiol is protective in a rat model of traumatic brain injury.
Day NL; Carle MS; Floyd CL
Neurochem Int; 2017 Dec; 111():57-68. PubMed ID: 28472639
[TBL] [Abstract][Full Text] [Related]
2. A Combination Therapy of 17β-Estradiol and Memantine Is More Neuroprotective Than Monotherapies in an Organotypic Brain Slice Culture Model of Traumatic Brain Injury.
Lamprecht MR; Morrison B
J Neurotrauma; 2015 Sep; 32(17):1361-8. PubMed ID: 25752651
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic effects of single dose memantine after controlled cortical impact injury in adult rats.
Abrahamson EE; Poloyac SM; Dixon CE; Dekosky ST; Ikonomovic MD
Restor Neurol Neurosci; 2019; 37(3):245-263. PubMed ID: 31177251
[TBL] [Abstract][Full Text] [Related]
4. 17β-estradiol rescues damages following traumatic brain injury from molecule to behavior in mice.
Lu H; Ma K; Jin L; Zhu H; Cao R
J Cell Physiol; 2018 Feb; 233(2):1712-1722. PubMed ID: 28681915
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats.
Rao VL; Dogan A; Todd KG; Bowen KK; Dempsey RJ
Brain Res; 2001 Aug; 911(1):96-100. PubMed ID: 11489449
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Memantine on Glutamic Receptor-Associated Nitrosative Stress in a Traumatic Brain Injury Rat Model.
Wang CC; Wee HY; Hu CY; Chio CC; Kuo JR
World Neurosurg; 2018 Apr; 112():e719-e731. PubMed ID: 29382619
[TBL] [Abstract][Full Text] [Related]
7. 17β-estradiol confers protection after traumatic brain injury in the rat and involves activation of G protein-coupled estrogen receptor 1.
Day NL; Floyd CL; D'Alessandro TL; Hubbard WJ; Chaudry IH
J Neurotrauma; 2013 Sep; 30(17):1531-41. PubMed ID: 23659385
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective properties of memantine in different in vitro and in vivo models of excitotoxicity.
Volbracht C; van Beek J; Zhu C; Blomgren K; Leist M
Eur J Neurosci; 2006 May; 23(10):2611-22. PubMed ID: 16817864
[TBL] [Abstract][Full Text] [Related]
9. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.
Lipton SA
Curr Drug Targets; 2007 May; 8(5):621-32. PubMed ID: 17504105
[TBL] [Abstract][Full Text] [Related]
10. Therapeutically relevant plasma concentrations of memantine produce significant L-N-methyl-D-aspartate receptor occupation and do not impair learning in rats.
Morè L; Gravius A; Nagel J; Valastro B; Greco S; Danysz W
Behav Pharmacol; 2008 Oct; 19(7):724-34. PubMed ID: 18797249
[TBL] [Abstract][Full Text] [Related]
11. Memantine Reduced Cell Death, Astrogliosis, and Functional Deficits in an in vitro Model of Repetitive Mild Traumatic Brain Injury.
Effgen GB; Morrison B
J Neurotrauma; 2017 Feb; 34(4):934-942. PubMed ID: 27450515
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of memantine combined with topiramate in hypoxic-ischemic brain injury.
Liu C; Lin N; Wu B; Qiu Y
Brain Res; 2009 Jul; 1282():173-82. PubMed ID: 19501064
[TBL] [Abstract][Full Text] [Related]
13. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
[TBL] [Abstract][Full Text] [Related]
14. The neuroprotective effect of 17β-estradiol is independent of its antioxidative properties.
Gröger M; Plesnila N
Brain Res; 2014 Nov; 1589():61-7. PubMed ID: 25148707
[TBL] [Abstract][Full Text] [Related]
15. The Role of Estradiol in Traumatic Brain Injury: Mechanism and Treatment Potential.
Kövesdi E; Szabó-Meleg E; Abrahám IM
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374952
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effects of a novel dimeric inhibitor of PSD-95 on excitotoxicity and functional recovery after experimental traumatic brain injury.
Sommer JB; Bach A; Malá H; Strømgaard K; Mogensen J; Pickering DS
Eur J Neurosci; 2017 Jan; 45(2):238-248. PubMed ID: 27859797
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol.
Culmsee C; Junker V; Kremers W; Thal S; Plesnila N; Krieglstein J
Stroke; 2004 May; 35(5):1197-202. PubMed ID: 15060319
[TBL] [Abstract][Full Text] [Related]
18. Cognitive dysfunction induced by sequential injection of amyloid-beta and ibotenate into the bilateral hippocampus; protection by memantine and MK-801.
Nakamura S; Murayama N; Noshita T; Katsuragi R; Ohno T
Eur J Pharmacol; 2006 Oct; 548(1-3):115-22. PubMed ID: 16952349
[TBL] [Abstract][Full Text] [Related]
19. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
Zhao L; Brinton RD
BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
[TBL] [Abstract][Full Text] [Related]
20. Memantine improves outcomes after repetitive traumatic brain injury.
Mei Z; Qiu J; Alcon S; Hashim J; Rotenberg A; Sun Y; Meehan WP; Mannix R
Behav Brain Res; 2018 Mar; 340():195-204. PubMed ID: 28412305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
